BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29480666)

  • 1. An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood – A Prognostic Clue?
    Das D; Sarkar B; Mukhopadhyay S; Banerjee C; Biswas Mondal S
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):471-478. PubMed ID: 29480666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.
    Shah W; Yan X; Jing L; Zhou Y; Chen H; Wang Y
    Cell Mol Immunol; 2011 Jan; 8(1):59-66. PubMed ID: 21200385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma.
    Sznurkowski JJ; Zawrocki A; Emerich J; Biernat W
    Int J Gynecol Cancer; 2011 May; 21(4):717-21. PubMed ID: 21543933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
    Piersma SJ; Jordanova ES; van Poelgeest MI; Kwappenberg KM; van der Hulst JM; Drijfhout JW; Melief CJ; Kenter GG; Fleuren GJ; Offringa R; van der Burg SH
    Cancer Res; 2007 Jan; 67(1):354-61. PubMed ID: 17210718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma.
    Sheu BC; Hsu SM; Ho HN; Lin RH; Torng PL; Huang SC
    Cancer; 1999 Oct; 86(8):1537-43. PubMed ID: 10526283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of peripheral blood and tumor tissue lymphocyte subsets in cervical cancer patients.
    Wu Y; Ye S; Goswami S; Pei X; Xiang L; Zhang X; Yang H
    BMC Cancer; 2020 Mar; 20(1):173. PubMed ID: 32131750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of T lymphocytes infiltration in breast cancer].
    Yu HM; Jiao SC; Yang JL; Wang JD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer.
    Horn T; Laus J; Seitz AK; Maurer T; Schmid SC; Wolf P; Haller B; Winkler M; Retz M; Nawroth R; Gschwend JE; Kübler HR; Slotta-Huspenina J
    World J Urol; 2016 Feb; 34(2):181-7. PubMed ID: 26055646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer.
    Wang K; Shen T; Siegal GP; Wei S
    Hum Pathol; 2017 Nov; 69():110-117. PubMed ID: 28993275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD4/CD8 ratio in vitreous fluid is of high diagnostic value in sarcoidosis.
    Kojima K; Maruyama K; Inaba T; Nagata K; Yasuhara T; Yoneda K; Sugita S; Mochizuki M; Kinoshita S
    Ophthalmology; 2012 Nov; 119(11):2386-92. PubMed ID: 22809758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
    Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
    Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells.
    Diederichsen AC; Hjelmborg Jv; Christensen PB; Zeuthen J; Fenger C
    Cancer Immunol Immunother; 2003 Jul; 52(7):423-8. PubMed ID: 12695859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-infiltrating lymphocytes in cervical carcinoma.
    Ghosh AK; Moore M
    Eur J Cancer; 1992; 28A(11):1910-6. PubMed ID: 1389534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic effects of tumor infiltrating regulatory T cells and myeloid derived suppressor cells assessed by multicolor flow cytometry in gastric cancer patients.
    Choi HS; Ha SY; Kim HM; Ahn SM; Kang MS; Kim KM; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kang ES
    Oncotarget; 2016 Feb; 7(7):7940-51. PubMed ID: 26799288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
    Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
    Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
    Matsumoto H; Thike AA; Li H; Yeong J; Koo SL; Dent RA; Tan PH; Iqbal J
    Breast Cancer Res Treat; 2016 Apr; 156(2):237-47. PubMed ID: 26960711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 lymphocytes in women with invasive and preinvasive cervical neoplasia.
    Gemignani M; Maiman M; Fruchter RG; Arrastia CD; Gibbon D; Ellison T
    Gynecol Oncol; 1995 Dec; 59(3):364-9. PubMed ID: 8522256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.